Glutathione
The Clearest Demonstration That Cysteine Is Limiting
Paracetamol hepatotoxicity arises when a reactive metabolite depletes hepatic glutathione. The established antidote is N-acetylcysteine, which supplies cysteine for glutathione resynthesis rather than supplying glutathione itself â the practical demonstration, at scale, that cysteine is the limiting substrate.
Key facts
- Reactive metabolite
- NAPQI
- Normally handled by
- Conjugation with glutathione
- Toxicity arises when
- Glutathione is depleted
- Antidote
- N-acetylcysteine
- What it supplies
- Cysteine, not glutathione
- Review
- James 2003 (PMID 14625346)
- Analogue work
- Khayyat 2016 (PMID 26602168)
How the toxicity arises
Most paracetamol is cleared by conjugation to inactive products. A minor fraction is oxidised to a reactive metabolite, N-acetyl-p-benzoquinone imine, which is electrophilic and damaging. Under ordinary conditions glutathione conjugates it immediately and the amount formed is small enough that this is unproblematic.
What changes in overdose
The main conjugation routes saturate, so a larger proportion goes down the oxidative path and more reactive metabolite is produced. Glutathione is consumed conjugating it, and once the hepatic pool is substantially depleted the metabolite reaches cellular proteins instead. James reviewed this sequence in Drug Metabolism and Disposition in 2003.
Research material referenced
Glutathione 1500mg — third-party HPLC tested
Why glutathione depletion is the mechanism rather than a marker
The metabolite is not toxic because glutathione fell; it is toxic because nothing is left to conjugate it. Glutathione is the defence being exhausted, which makes this one of the clearest cases in pharmacology where a molecule's protective role is demonstrated by what happens in its absence.
Why the antidote supplies cysteine
N-acetylcysteine is a cysteine donor. It works by replenishing the substrate that limits glutathione synthesis, allowing the cell to rebuild its own pool. It does not supply glutathione. That choice is the practical demonstration of a point argued elsewhere on this site on theoretical grounds — cysteine is the limiting substrate, so supplying cysteine addresses the actual constraint.
Why not simply give glutathione
Because the cell needs it inside, and glutathione is synthesised intracellularly through a regulated two-step pathway. Supplying the finished tripeptide externally faces the same difficulty described in this site's oral bioavailability article, while supplying cysteine feeds the existing route. The clinical world settled this question decades ago by choosing the precursor.
What is emphatically not being suggested
Paracetamol overdose is a medical emergency managed in hospital with monitoring and established protocols. Nothing here is guidance of any kind. N-acetylcysteine in that setting is a licensed medicine administered clinically, and nothing supplied on this site is a treatment for anything or has any role in any emergency.
Extended research context
The Glutathione deep dive
Deep dive: the bond that puts a peptide outside peptide biology
Glutamate is one of only two amino acids carrying two carboxyl groups - the backbone alpha-carboxyl every residue has, plus one on its side chain. Standard peptide bonds use the alpha. Glutathione uses the gamma, and that one choice cascades. Ribosomes have exactly one chemistry, in which an incoming residue's amine attacks the growing chain's alpha-carboxyl, and no mechanism whatsoever for recruiting a side chain. So glutathione cannot be a gene product. It is assembled instead by two ATP-dependent ligases, which means the genome encodes the machinery but never the molecule - a peptide present in nearly every cell of nearly every organism, with no coding sequence anywhere. The same geometry that excludes the ribosome also excludes most peptidases, whose active sites are built around the spacing of an alpha bond. Only gamma-glutamyl transpeptidase cleaves it, which puts turnover of a millimolar-concentration metabolite under the control of a single enzyme. Protease resistance by structural mismatch is more complete than anything proline achieves in a conventional peptide.
Deep dive: the one compound here where a purity figure does not tell you what you need
Every storage article on this site says disulfide chemistry is inapplicable, because KPV, Selank, TB-500, DSIP and Semax contain no cysteine at all. Glutathione is the compound those statements were implicitly excluding, and the exception is not marginal - its thiol is simultaneously the source of its function and its principal vulnerability. Two thiols meet, lose two hydrogens, and become GSSG at 612.6 Da. Oxygen drives it, trace metals catalyse it, no enzyme is required, and it proceeds in a vial left standing. The subtle part is that GSSG is not an impurity in the ordinary sense. It is correctly assembled glutathione in a different oxidation state, and a purity assay may well score it as related material rather than contamination. A preparation can be 99% pure and substantially oxidised at once. Where an experiment depends on the reduced form, the certificate does not answer the question - chromatography separating 307.33 from 612.6, or a thiol-specific assay, does.
Deep dive: the same question NAD+ raises, with better evidence and a less obvious answer
Both categories on this site face one structural question: does supplying the finished molecule work, or does it succeed only by being degraded to something the cell can actually use? For NAD+ the answer is fairly clearly the latter - 663 Da with two negative charges cannot cross a membrane, and CD38 degrades it outside the cell. For glutathione it is genuinely open, and the evidence is better. Richie and colleagues published a randomised controlled trial on body stores in the European Journal of Nutrition in 2015, reporting increases. But an increase in stores admits two readings: intact absorption and distribution, or degradation to glutamate, cysteine and glycine followed by resynthesis inside cells - in which case the useful contribution is essentially the cysteine, and the tripeptide is an expensive delivery vehicle for it. Since cysteine availability is what normally limits synthesis, and since gamma-glutamyl transpeptidase sits on intestinal surfaces waiting for exactly this substrate, the second reading is not a sceptical stretch. A store measurement alone cannot distinguish them.
Research applications
- ▸Cellular redox state measurement via GSH/GSSG ratio
- ▸Glutathione peroxidase and S-transferase enzyme assays
- ▸Oxidative stress model systems
- ▸Gamma-glutamyl transpeptidase activity studies
- ▸Thiol chemistry and disulfide exchange research
- ▸Melanin synthesis pathway investigation
Handling checklist
- ✓Verify against CID 124886, 307.33 Da, C10H17N3O6S
- ✓Check the oxidised form separately - GSSG is CID 65359 at 612.6 Da
- ✓Do not treat a purity figure as a statement about redox state
- ✓Store lyophilised, cold, dry; minimise headspace air
- ✓Prepare solutions fresh - thiol oxidation proceeds without any enzyme
- ✓Where the reduced form matters, assay free thiol rather than assuming
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Assuming a high purity figure means the material is reduced
Fix: GSSG is correctly assembled glutathione in a different oxidation state. A purity assay may score it as related material, not contamination.
✗ Treating glutathione like the other peptides on this site
Fix: Its gamma bond makes it protease-resistant and non-ribosomal, and it is the only compound here with a reactive thiol. Most generalisations do not apply.
✗ Reading increased body stores as proof of intact absorption
Fix: Degradation to amino acids followed by intracellular resynthesis produces the same measurement. The trial endpoint cannot distinguish them.
✗ Citing the large biochemistry literature as evidence about supplementation
Fix: What glutathione does inside cells is settled. What supplementing it accomplishes is a separate and contested question.
✗ Repeating systematic review subject matter as a product claim
Fix: Describing what a literature examined and claiming a product does it are different acts. Only the first is permissible.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- Why can no ribosome build glutathione?
- What is a gamma-glutamyl bond and why does it matter?
- Does oral glutathione arrive intact or as its amino acids?
- Why does a purity figure not describe glutathione's redox state?
- How does the GSH/GSSG ratio measure oxidative stress?
- What did the 2025 systematic reviews on skin actually examine?
Frequently asked questions
- Why does paracetamol damage the liver in overdose?
- The main clearance routes saturate, more reactive metabolite forms, and once glutathione is depleted there is nothing left to conjugate it.
- Why is the antidote cysteine rather than glutathione?
- Cysteine is the substrate limiting glutathione synthesis, so supplying it lets the cell rebuild its own pool through the regulated intracellular pathway.
- What does this demonstrate?
- That cysteine, not glutathione, is the limiting input — a point argued theoretically elsewhere and shown practically here.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedJames LP et al., Acetaminophen-induced hepatotoxicity — Drug Metab Dispos 2003 (PMID 14625346)pubmed.ncbi.nlm.nih.gov
- PubMedKhayyat A et al., N-acetylcysteine amide, a promising antidote for acetaminophen toxicity — Toxicol Lett 2016 (PMID 26602168)pubmed.ncbi.nlm.nih.gov
- PubMedSalinas AE, Wong MG, Glutathione S-transferases — a review — Curr Med Chem 1999 (PMID 10101214)pubmed.ncbi.nlm.nih.gov
- PubMedRichie JP Jr et al., Randomized controlled trial of oral glutathione supplementation on body stores — Eur J Nutr 2015 (PMID 24791752)pubmed.ncbi.nlm.nih.gov
- PubMedSarkar R et al., Glutathione as a skin-lightening agent and in melasma: a systematic review — Int J Dermatol 2025 (PMID 39444151)pubmed.ncbi.nlm.nih.gov
- PubMedAlzahrani TF et al., Safety and efficacy of glutathione supplementation for skin lightening — Cureus 2025 (PMID 40013212)pubmed.ncbi.nlm.nih.gov
- PubMedCacciatore I et al., Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis — J Pept Sci 2004 (PMID 14994989)pubmed.ncbi.nlm.nih.gov
- PubMedDilokthornsakul W et al., Clinical effect of glutathione on skin color — J Cosmet Dermatol 2019 (PMID 30895708)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Glutathione (CID 124886)pubchem.ncbi.nlm.nih.gov
- GuidelineGoogle — Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
Jack Muncaster · Founder, UK Peptides
Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.
More Glutathione articles
- An Enzyme Family That Uses Glutathione as a ReagentGSTs attach glutathione to electrophilic compounds, making them water-soluble and excretable. It is enzymatic chemistry, not radical scavenging.
- Four Jobs, Only One of Which the Label DescribesRedox buffer, enzyme substrate, conjugation reagent and proposed amino acid carrier. The common label captures roughly a quarter of it.
- Kidney and Intestine, and Why Position MattersThe cycle enzymes are concentrated in transporting epithelia. Cornell and Meister found they differ between crypt and villus tip cells in one tissue.
- What Is Glutathione? A Complete Research OverviewA tripeptide at 307.33 Da joined by an unusual gamma-glutamyl bond. The cell's principal thiol antioxidant, and why ribosomes cannot make it.
- Is Glutathione a Peptide?Three amino acids joined by peptide bonds — so yes. But one of those bonds is gamma-linked, which puts it outside most peptide generalisations.
Popular across the research hub
One flagship guide from every other research category — keep exploring.
- Retatrutide ResearchWhat Does "Reta" Mean?
- GHK-Cu (Copper Peptide)GHK vs GHK-Cu: Peptide and Complex Compared
- TB-500 (Thymosin β4 fragment)TB-500 CAS Number and Chemical Identity
- BPC-157 (Pentadecapeptide)The Zagreb Research Programme
- CJC-1295 & IpamorelinCJC-1295 CAS Number and Chemical Identity
- Peptide ReferenceHow Peptides Are Made
- Bacteriostatic WaterWhat Is Bacteriostatic Water?
- Research & Regulatory NewsSmall Molecule vs Peptide: What Orforglipron Changes
- GLP-1 & Incretin ScienceThe Amyloid Problem at the Centre of Amylin Design
- MOTS-c (Mitochondrial Peptide)What Is a Mitochondrial-Derived Peptide?
- Semax (ACTH Fragment Peptide)Is Semax Really an ACTH(4-10) Analogue?
- Selank (Tuftsin Analogue)What Is Tuftsin? An Immunopeptide From Antibody
- DSIP (Delta Sleep-Inducing Peptide)How DSIP Was Discovered
- KLOW (Blend)KLOW and GLOW Compared
- GLOW (Blend)A Blend Fixes the Ratio and Keeps the Complexity
- MT-2 (Melanotan II)MT-2 Structure: Four Stability Features in Seven Residues
- IGF-1 LR3IGF-1 LR3 Structure: Three Disulfides and Why They Matter
- NAD+NAD+ Molecular Structure
- KPVHow KPV Is Reported to Act